Ferring Pharmaceuticals Inc. et al v. Finch Therapeutics Group, Inc. et al
Plaintiff: Ferring Pharmaceuticals Inc. and Rebiotix Inc.
Defendant: Finch Therapeutics Group, Inc., Finch Therapeutics, Inc. and Finch Therapeutics Holdings, LLC.
Counter Claimant: Regents of the University of Minnesota
Case Number: 1:2021cv01694
Filed: December 1, 2021
Court: US District Court for the District of Delaware
Presiding Judge: Richard G Andrews
Nature of Suit: Patent
Cause of Action: 35 U.S.C. § 1 Patent Infringement
Jury Demanded By: Defendant
RSS RSS Track this Docket
Docket Report

This docket was last retrieved on March 17, 2023. A more recent docket listing may be available from PACER.

Date Filed Document Text
March 17, 2023 Filing 153 MOTION for Pro Hac Vice Appearance of Attorney Ingrid Petersen - filed by Finch Therapeutics Group, Inc., Finch Therapeutics Holdings, LLC., Finch Therapeutics, Inc., Regents of the University of Minnesota. (Pedi, Nicole)
March 17, 2023 Opinion or Order SO ORDERED, re #153 MOTION for Pro Hac Vice Appearance of Attorney Ingrid Petersen, filed by Finch Therapeutics, Inc., Finch Therapeutics Group, Inc., Finch Therapeutics Holdings, LLC., Regents of the University of Minnesota. Signed by Judge Richard G. Andrews on 3/17/2023. (nms)
March 15, 2023 Filing 152 NOTICE OF SERVICE of Ferring/Rebiotix's Objections and Responses to Finch/UMN's Fourth Set of Interrogatories (No. 19) filed by Ferring Pharmaceuticals Inc., Rebiotix Inc..(Bourke, Mary)
March 10, 2023 Filing 151 NOTICE OF SERVICE of (1) Ferring/Rebiotix's Second Supplemental Objections and Response to Finch/UMN's Interrogatory No. 1, (2) Plaintiffs Ferring Pharmaceuticals Inc. and Rebiotix Inc.'s Supplemental Invalidity Contentions for the Asserted Claims of United States Patent Numbers 10,251,914, 10,286,011, and 10,286,012, and (3) Plaintiffs Ferring Pharmaceuticals Inc. and Rebiotix Inc.'s Supplemental Invalidity Contentions for the Asserted Claims of United States Patent Numbers 10,022,406, 9,962,413, 10,328,107, 10,463,702, 10,675,309, 11,541,080 and 11,491,193, filed by Ferring Pharmaceuticals Inc., Rebiotix Inc..(Bourke, Mary)
March 7, 2023 Filing 150 NOTICE OF SERVICE of Plaintiffs' Objections and Responses to Counterclaimants' Notice of Deposition of Plaintiffs filed by Ferring Pharmaceuticals Inc., Rebiotix Inc..(Bourke, Mary)
March 7, 2023 Filing 149 NOTICE OF SERVICE of (1) Counterclaim- Plaintiff Regents of The University of Minnesota's Objections and Responses to Ferring's Third Set of Requests for the Production of Documents and Things (Nos. 137-147) and (2) Counterclaim-Plaintiff Finch Therapeutics Group, Inc., Finch Therapeutics, Inc., and Finch Therapeutics Holdings, LLC Objections and Responses to Plaintiffs' Third Set of Requests for the Production of Documents and Things (Nos. 132-156) filed by Finch Therapeutics Group, Inc., Finch Therapeutics Holdings, LLC., Finch Therapeutics, Inc., Regents of the University of Minnesota.(Farnan, Kelly)
March 7, 2023 Filing 148 Official Transcript of Markman Hearing held on 2/21/23 before Judge Richard G. Andrews. Court Reporter Heather M. Triozzi,Email: Heather_Triozzi@ded.uscourts.gov. Transcript may be viewed at the court public terminal or order/purchased through the Court Reporter before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 3/28/2023. Redacted Transcript Deadline set for 4/10/2023. Release of Transcript Restriction set for 6/5/2023. (Triozzi, Heather)
March 2, 2023 Opinion or Order SO ORDERED, re #147 STIPULATION and Proposed Order to serve supplemental invalidity contentions and supplemental interrogatory responses to March 10, 2023 and March 31, 2023. Signed by Judge Richard G. Andrews on 3/2/2023. (nms)
March 1, 2023 Filing 147 STIPULATION TO EXTEND TIME to serve supplemental invalidity contentions and supplemental interrogatory responses to March 10, 2023 and March 31, 2023 - filed by Ferring Pharmaceuticals Inc., Rebiotix Inc.. (Bourke, Mary)
March 1, 2023 Filing 146 NOTICE OF SERVICE of Plaintiffs' Third Set of Interrogatories to Finch Therapeutics Group, Inc., Finch Therapeutics, Inc., Finch Therapeutics Holdings, LLC, and the Regents of the University of Minnesota (Nos. 13-18) filed by Ferring Pharmaceuticals Inc., Rebiotix Inc..(Bourke, Mary)
February 28, 2023 Opinion or Order Filing 145 CLAIM CONSTRUCTION ORDER. Signed by Judge Richard G. Andrews on 2/28/2023. (nms)
February 28, 2023 Filing 144 NOTICE OF SERVICE of (1) Notice of Deposition of the Regents of the University of Minnesota (2) Notice of Deposition of Finch Therapeutics Group, Inc., Finch Therapeutics, Inc., Finch Therapeutics Holdings, LLC filed by Ferring Pharmaceuticals Inc., Rebiotix Inc..(Attaway, Daniel)
February 27, 2023 Filing 143 NOTICE OF SERVICE of Plaintiffs' Objections and Responses to Finch and UMN's Third Set of Interrogatories (Nos. 10-18) filed by Ferring Pharmaceuticals Inc., Rebiotix Inc..(Bourke, Mary)
February 27, 2023 Filing 142 Joint Claim Construction Order, by Finch Therapeutics Group, Inc., Finch Therapeutics Holdings, LLC., Finch Therapeutics, Inc., Regents of the University of Minnesota. (Farnan, Kelly) Modified on 2/28/2023 (nms).
February 23, 2023 Pro Hac Vice Attorney Ashley Cade and Leslie M. Schmidt for Finch Therapeutics Group, Inc., Finch Therapeutics Holdings, LLC., Finch Therapeutics, Inc., and Regents of the University of Minnesota added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb)
February 22, 2023 Filing 141 NOTICE OF SERVICE of Non-Party Dr. Benjamin Merrifield's Objections and Responses to Counterclaimants' Notice of Subpoena filed by Ferring Pharmaceuticals Inc., Rebiotix Inc..(Attaway, Daniel)
February 22, 2023 Filing 140 NOTICE of Subpoena to William Kieper to Testify at Deposition by Ferring Pharmaceuticals Inc., Rebiotix Inc. (Attachments: #1 Exhibit A)(Bourke, Mary)
February 21, 2023 Filing 139 ANSWER to #126 Answer to Counterclaim, by Finch Therapeutics Group, Inc., Finch Therapeutics Holdings, LLC., Finch Therapeutics, Inc., Regents of the University of Minnesota.(Farnan, Kelly) Modified on 2/21/2023 (nms).
February 21, 2023 Minute Entry for proceedings held before Judge Richard G. Andrews - Markman Hearing held on 2/21/2023. Counsel for Plaintiffs: M. Bourke, B. Bourke, D. Attaway, D. Severance. Counsel for Defendants: K. Farnan. Counsel is directed to submit a proposed order construing the terms as the Court has construed them at the hearing, by 2/27/2023. (Court Reporter Heather Triozzi.) (lah)
February 20, 2023 Filing 138 Letter to The Honorable Richard G. Andrews, from Mary W. Bourke, regarding response to February 17, 2023 order regarding claim construction (D.I. #134 ). (Bourke, Mary) Modified on 2/20/2023 (nms).
February 20, 2023 Filing 137 Supplemental Claim Construction Submission, by Finch Therapeutics Group, Inc., Finch Therapeutics Holdings, LLC., Finch Therapeutics, Inc., Regents of the University of Minnesota. (Farnan, Kelly) Modified on 2/20/2023 (nms).
February 20, 2023 Filing 136 NOTICE OF SERVICE of (1) Plaintiffs' First Supplemental Objections and Responses to Finch and UMN's First Set of Interrogatories (Nos. 1-7) and (2) Plaintiffs' First Supplemental Objections and Responses to Finch and UMN's Second Set of Interrogatories (Nos. 8-9) filed by Ferring Pharmaceuticals Inc., Rebiotix Inc..(Attaway, Daniel)
February 17, 2023 Filing 135 NOTICE OF SERVICE of Counterclaim Plaintiffs Finch Therapeutics Group, Inc., Finch Therapeutics, Inc., Finch Therapeutics Holdings, LLC and the Regents of the University of Minnesota's Supplemental Infringement Contentions filed by Finch Therapeutics Group, Inc., Finch Therapeutics Holdings, LLC., Finch Therapeutics, Inc., Regents of the University of Minnesota.(Pedi, Nicole)
February 17, 2023 Opinion or Order Filing 134 MARKMAN ORDER: In connection with the scheduled Markman hearing, the Court advises as follows: For the terms microbiota and substantially entire microbiota (D.I. #91 at 40), each party is to state whether microbiota would have had a plain and ordinary meaning to a POSA at the relevant time period, and, if so, what it would be. Finch is also to provide a construction for substantially entire microbiota. For the term extract (D.I. #91 at 60), each party is to provide a construction of that term as a POSA would have understood it at the relevant time period. If either party is proposing that it has a different meaning based on intrinsic evidence, the party should state what that is.For the last disputed term (D.I. #91 at 71), each party is to state what their position is about whether a pharmaceutically acceptable carrier would, might, or would not include a diluent. For the term effective amount (D.I. #9 at 47), the Court adopts Finchs proposed construction. For the Markush group term (D.I. #91 at 53), no construction is necessary. The parties submissions shall be filed by Monday, February 20, 2023, at 2 p.m. The parties are requested not to submit argument with their submissions. Signed by Judge Richard G. Andrews on 2/17/2023. (nms)
February 15, 2023 Filing 133 NOTICE of Subpoena to Janet Jansson to Testify at Deposition, by Ferring Pharmaceuticals Inc., Rebiotix Inc.. (Attachments: #1 Exhibit)(Bourke, Mary) Modified on 2/15/2023 (nms).
February 14, 2023 Opinion or Order SO ORDERED, re #132 MOTION for Pro Hac Vice Appearance of Attorney Leslie M. Schmidt and Ashley Cade, filed by Finch Therapeutics, Inc., Finch Therapeutics Group, Inc., Finch Therapeutics Holdings, LLC., Regents of the University of Minnesota. Signed by Judge Richard G. Andrews on 2/14/2023. (nms)
February 13, 2023 Filing 132 MOTION for Pro Hac Vice Appearance of Attorney Leslie M. Schmidt and Ashley Cade - filed by Finch Therapeutics Group, Inc., Finch Therapeutics Holdings, LLC., Finch Therapeutics, Inc., Regents of the University of Minnesota. (Pedi, Nicole)
February 13, 2023 Filing 131 NOTICE OF SERVICE of Counterclaim Plaintiffs' Finch Therapeutics Group, Inc., Finch Therapeutics, Inc., Finch Therapeutics Holdings, LLC, and the Regents of the University of Minnesotas Fourth Set of Interrogatories (No. 19) filed by Finch Therapeutics Group, Inc., Finch Therapeutics Holdings, LLC., Finch Therapeutics, Inc., Regents of the University of Minnesota.(Pedi, Nicole)
February 13, 2023 Filing 130 NOTICE of Deposition of Plaintiffs by Finch Therapeutics Group, Inc., Finch Therapeutics Holdings, LLC., Finch Therapeutics, Inc., Regents of the University of Minnesota (Attachments: #1 Exhibit A)(Pedi, Nicole)
February 13, 2023 Opinion or Order Filing 129 SO ORDERED Granting #128 Stipulation and Proposed Order Regarding Claim Construction of United States Patent Numbers 11,491,193 and 11,541,080. Signed by Judge Richard G. Andrews on 2/13/2023. (nms)
February 13, 2023 Filing 128 STIPULATION regarding Claim Construction of United States Patent Numbers 11,491,193 and 11,541,080 by Finch Therapeutics Group, Inc., Finch Therapeutics Holdings, LLC., Finch Therapeutics, Inc., Regents of the University of Minnesota. (Pedi, Nicole)
February 8, 2023 Filing 127 NOTICE of of subpoena duces tecum to Ben Merrifield by Finch Therapeutics Group, Inc., Finch Therapeutics Holdings, LLC., Finch Therapeutics, Inc., Regents of the University of Minnesota (Attachments: #1 Exhibit A)(Pedi, Nicole)
February 7, 2023 Filing 126 ANSWER to #98 Amended Answer to Complaint, and COUNTERCLAIMS against Finch Therapeutics Group, Inc., Finch Therapeutics Holdings, LLC., Finch Therapeutics, Inc., Regents of the University of Minnesota, by Rebiotix Inc., Ferring Pharmaceuticals Inc.. (Attachments: #1 Exhibit 1, #2 Exhibit 2, #3 Exhibit 3, #4 Exhibit 4, #5 Exhibit 5, #6 Exhibit 6, #7 Exhibit 7, #8 Exhibit 8, #9 Exhibit 9, #10 Exhibit 10, #11 Exhibit 11, #12 Exhibit 12)(Bourke, Mary) Modified on 2/7/2023 (nms).
February 6, 2023 Opinion or Order Filing 125 SO ORDERED Granting #124 Stipulation and Proposed Order Regarding Scheduling. Signed by Judge Richard G. Andrews on 2/6/2023. (nms)
February 6, 2023 Filing 124 STIPULATION and Proposed Order Regarding Scheduling, by Finch Therapeutics Group, Inc., Finch Therapeutics Holdings, LLC., Finch Therapeutics, Inc., Regents of the University of Minnesota. (Farnan, Kelly) Modified on 2/6/2023 (nms).
February 6, 2023 Filing 123 STIPULATION and Proposed Order to Extend Time - filed by Ferring Pharmaceuticals Inc., Rebiotix Inc.. (Attaway, Daniel) Modified on 2/6/2023 (nms).
February 6, 2023 Filing 122 NOTICE OF SERVICE of (1) Plaintiffs' Fourth Set of Requests to the Regents of the University of Minnesota for the Production of Documents and Things (Nos. 137-147) and (2) Plaintiffs' Third Set of Requests to Finch Therapeutics Group, Inc., Finch Therapeutics, Inc., and Finch Therapeutics Holdings, LLC for the Production of Documents and Things (Nos. 132-156) filed by Ferring Pharmaceuticals Inc., Rebiotix Inc..(Attaway, Daniel)
February 6, 2023 Opinion or Order SO ORDERED, re #123 STIPULATION and Proposed Order to Extend Time (*Reset Answer Deadlines: Ferring Pharmaceuticals Inc. answer due 2/7/2023; Rebiotix Inc. answer due 2/7/2023). Signed by Judge Richard G. Andrews on 2/6/2023. (nms)
February 3, 2023 Filing 121 NOTICE OF SERVICE of (1) Counterclaim Plaintiffs' Responses and Objections to Plaintiffs' Second Set of Interrogatories to Finch Therapeutics Group, Inc., Finch Therapeutics, Inc., Finch Therapeutics Holdings, LLC, and the Regents of the University of Minnesota (Nos. 9-12) and (2) Counterclaim-Plaintiff Regents of the University of Minnesota's Objections and Responses to Plaintiffs' Second Set of Requests for the Production of Documents and Things (Nos. 130-136) filed by Finch Therapeutics Group, Inc., Finch Therapeutics Holdings, LLC., Finch Therapeutics, Inc., Regents of the University of Minnesota.(Farnan, Kelly)
February 2, 2023 Filing 120 NOTICE of Subpoena to Ben Merrifield to Testify at a Deposition by Finch Therapeutics Group, Inc., Finch Therapeutics Holdings, LLC., Finch Therapeutics, Inc., Regents of the University of Minnesota (Attachments: #1 Exhibit A)(Pedi, Nicole)
February 2, 2023 Filing 119 NOTICE of Subpoena to Janet Jansson to Testify at a Deposition by Finch Therapeutics Group, Inc., Finch Therapeutics Holdings, LLC., Finch Therapeutics, Inc., Regents of the University of Minnesota (Attachments: #1 Exhibit A)(Pedi, Nicole)
February 2, 2023 Opinion or Order Filing 118 ORDER: Within two weeks and one day of this Order, Plaintiffs/Counterclaim Defendants Ferring Pharmaceuticals Inc. and Rebiotix, Inc. shall supplement their response to Interrogatory No. 1 to provide the specific factual bases for its contentions that REBYOTA (1) contains at least one particle greater than 0.5 mm and (2) contains particles that are not capable of passing through a 0.5 mm sieve. Signed by Judge Richard G. Andrews on 2/2/2023. (lah)
February 2, 2023 Opinion or Order Filing 117 ORAL ORDER: The redactions (D.I. #106 ; D.I. #107 ) as supported by the Declaration (D.I. #108 ) are APPROVED. Ordered by Judge Richard G. Andrews on 2/2/2023. (nms)
February 2, 2023 Minute Entry for proceedings held before Judge Richard G. Andrews - Discovery Conference held on 2/2/2023. Counsel for Plaintiffs: M. Bourke. Counsel for Defendants: K. Farnan. The transcript shall serve as the memorialization of the Court's ruling. (Court Reporter Heather Triozzi.) (lah)
February 1, 2023 Filing 116 NOTICE of Subpoena to Edwin Hlavka to Testify at a Deposition by Finch Therapeutics Group, Inc., Finch Therapeutics Holdings, LLC., Finch Therapeutics, Inc., Regents of the University of Minnesota (Attachments: #1 Exhibit A)(Pedi, Nicole)
February 1, 2023 Filing 115 NOTICE to Take Deposition of David Bell filed by Finch Therapeutics Group, Inc., Finch Therapeutics Holdings, LLC., Finch Therapeutics, Inc., Regents of the University of Minnesota.(Pedi, Nicole)
February 1, 2023 Filing 114 NOTICE to Take Deposition of Lee Jones filed by Finch Therapeutics Group, Inc., Finch Therapeutics Holdings, LLC., Finch Therapeutics, Inc., Regents of the University of Minnesota.(Pedi, Nicole)
February 1, 2023 Filing 113 NOTICE to Take Deposition of Gregory Fluet filed by Finch Therapeutics Group, Inc., Finch Therapeutics Holdings, LLC., Finch Therapeutics, Inc., Regents of the University of Minnesota.(Pedi, Nicole)
February 1, 2023 Filing 112 NOTICE to Take Deposition of Courtney Jones filed by Finch Therapeutics Group, Inc., Finch Therapeutics Holdings, LLC., Finch Therapeutics, Inc., Regents of the University of Minnesota.(Pedi, Nicole)
February 1, 2023 Filing 111 NOTICE to Take Deposition of Jennifer Accumanno filed by Finch Therapeutics Group, Inc., Finch Therapeutics Holdings, LLC., Finch Therapeutics, Inc., Regents of the University of Minnesota.(Pedi, Nicole)
February 1, 2023 Filing 110 NOTICE to Take Deposition of Kenneth Blount filed by Finch Therapeutics Group, Inc., Finch Therapeutics Holdings, LLC., Finch Therapeutics, Inc., Regents of the University of Minnesota.(Pedi, Nicole)
February 1, 2023 Filing 109 NOTICE to Take Deposition of Karen Kuphal filed by Finch Therapeutics Group, Inc., Finch Therapeutics Holdings, LLC., Finch Therapeutics, Inc., Regents of the University of Minnesota.(Pedi, Nicole)
February 1, 2023 Filing 108 DECLARATION re #107 Redacted Document, #106 Redacted Document, by Ferring Pharmaceuticals Inc., Rebiotix Inc.. (Bourke, Mary)
February 1, 2023 Filing 107 REDACTED VERSION of #100 Letter, by Ferring Pharmaceuticals Inc., Rebiotix Inc.. (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Exhibit C, #4 Exhibit D, #5 Exhibit E, #6 Exhibit F, #7 Exhibit G, #8 Text of Proposed Order, #9 Certificate of Service)(Bourke, Mary)
February 1, 2023 Filing 106 REDACTED VERSION of #99 Letter by Finch Therapeutics Group, Inc., Finch Therapeutics Holdings, LLC., Finch Therapeutics, Inc., Regents of the University of Minnesota. (Attachments: #1 Text of Proposed Order, #2 Exhibit 1-12)(Pedi, Nicole)
February 1, 2023 Opinion or Order SO ORDERED, re #105 STIPULATION and Proposed Order to Extend Deadline to File Redactions to February 1, 2023. Signed by Judge Richard G. Andrews on 2/1/2023. (nms)
January 31, 2023 Filing 105 STIPULATION and Proposed Order to Extend Deadline to File Redactions to February 1, 2023 - filed by Finch Therapeutics Group, Inc., Finch Therapeutics Holdings, LLC., Finch Therapeutics, Inc., Regents of the University of Minnesota. (Pedi, Nicole) Modified on 2/1/2023 (nms).
January 28, 2023 Filing 104 NOTICE OF SERVICE of Plaintiffs' First Amended Rule 26(a)(1)(A) and Paragraph 3 Disclosures filed by Ferring Pharmaceuticals Inc., Rebiotix Inc..(Attaway, Daniel)
January 27, 2023 Filing 103 NOTICE OF SERVICE of Plaintiffs' Objections and Responses to Counterclaimants' Fourth Set of Requests for Production of Documents and Things (Nos. 141-154) filed by Ferring Pharmaceuticals Inc., Rebiotix Inc..(Attaway, Daniel)
January 27, 2023 Filing 102 NOTICE OF SERVICE of Finch Therapeutics Group, Inc., Finch Therapeutics, Inc., Finch Therapeutics Holdings, LLC and The Regents of the University of Minnesota's Initial Infringement Contentions Against Ferring Pharmaceuticals Inc. and Rebiotix Inc.'s RBX2660 Product Associated with BLA No. 125739 for U.S. Patent Nos. 11,491,193 and 11,541,080 filed by Ferring Pharmaceuticals Inc., Finch Therapeutics Group, Inc., Finch Therapeutics Holdings, LLC., Finch Therapeutics, Inc..(Farnan, Kelly)
January 26, 2023 Filing 101 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 11,491,193; 11,541,080. (Pedi, Nicole) Modified on 1/27/2023 (nms).
January 26, 2023 Filing 100 [SEALED] Letter to the Honorable Richard G. Andrews, from Mary W. Bourke, regarding response to Discovery Dispute. (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Exhibit C, #4 Exhibit D, #5 Exhibit E, #6 Exhibit F, #7 Exhibit G, #8 Proposed Order, #9 Certificate of Service)(Bourke, Mary) Modified on 1/26/2023 (nms).
January 24, 2023 Filing 99 [SEALED] Letter to The Honorable Richard G. Andrews, from Kelly E. Farnan, regarding discovery dispute. (Attachments: #1 Proposed Order, #2 Exhibits 1-12)(Farnan, Kelly) Modified on 1/25/2023 (nms).
January 23, 2023 Filing 98 SECOND AMENDED Counterclaims and Answer to #1 Complaint and Affirmative Defenses, by Finch Therapeutics Group, Inc., Finch Therapeutics, Inc., Regents of the University of Minnesota, Finch Therapeutics Holdings, LLC.. (nms)
January 23, 2023 Opinion or Order Filing 97 SO ORDERED Granting #95 Stipulation and Proposed Order Regarding Second Amended Counterclaims. Signed by Judge Richard G. Andrews on 1/23/2023. (nms)
January 23, 2023 Opinion or Order Filing 96 SO ORDERED Granting #94 Joint Motion Requesting Claim Constuction Hearing. Signed by Judge Richard G. Andrews on 1/23/2023. (nms)
January 20, 2023 Filing 95 STIPULATION and [Proposed] Order Regarding Second Amended Counterclaim by Finch Therapeutics Group, Inc., Finch Therapeutics Holdings, LLC., Regents of the University of Minnesota. (Attachments: #1 Exhibit 1, #2 Exhibit 2)(Pedi, Nicole)
January 20, 2023 Filing 94 Joint Motion Requesting Claim Constuction Hearing - filed by Ferring Pharmaceuticals Inc., Rebiotix Inc.. (Bourke, Mary) Modified on 1/23/2023 (nms).
January 20, 2023 Filing 93 Joint Appendix, Volume 2 of 2 #91 Joint Claim Construction Brief, by Ferring Pharmaceuticals Inc., Rebiotix Inc.. (Attachments: #1 Exhibit 66, #2 Exhibit 67, #3 Exhibit 68, #4 Exhibit 69)(Bourke, Mary) Modified on 1/23/2023 (nms).
January 20, 2023 Filing 92 Joint Appendix, Volume 1 of 2 re #91 Joint Claim Construction Brief , by Ferring Pharmaceuticals Inc., Rebiotix Inc.. (Attachments: #1 Exhibit 1, #2 Exhibit 2, #3 Exhibit 3, #4 Exhibit 4, #5 Exhibit 5, #6 Exhibit 6, #7 Exhibit 7, #8 Exhibit 8, #9 Exhibit 13, #10 Exhibit 19, #11 Exhibit 20, #12 Exhibit 21, #13 Exhibit 22, #14 Exhibit 23, #15 Exhibit 24, #16 Exhibit 25, #17 Exhibit 35, #18 Exhibit 36, #19 Exhibit 37, #20 Exhibit 38, #21 Exhibit 43, #22 Exhibit 53, #23 Exhibit 54, #24 Exhibit 55, #25 Exhibit 56, #26 Exhibit 57, #27 Exhibit 58, #28 Exhibit 59, #29 Exhibit 60, #30 Exhibit 61, #31 Exhibit 62, #32 Exhibit 63, #33 Exhibit 64, #34 Exhibit 65)(Bourke, Mary) Modified on 1/23/2023 (nms).
January 20, 2023 Filing 91 JOINT Claim Construction Brief, filed by Ferring Pharmaceuticals Inc., Rebiotix Inc.. (Bourke, Mary) Modified on 1/23/2023 (nms).
January 19, 2023 Filing 90 NOTICE of Subpoena to Testify at Deposition Directed to Alexa Weingarden by Ferring Pharmaceuticals Inc., Rebiotix Inc. (Bourke, Mary)
January 12, 2023 Filing 89 NOTICE OF SERVICE of Counterclaim-Plaintiffs Third Set of Interrogatories (Nos. 10-18) filed by Finch Therapeutics Group, Inc., Finch Therapeutics Holdings, LLC., Finch Therapeutics, Inc., Regents of the University of Minnesota.(Farnan, Kelly)
January 9, 2023 Filing 88 NOTICE to Take Deposition of Alexa Weingarden on between May 1, 2023 and May 25, 2023 filed by Ferring Pharmaceuticals Inc., Rebiotix Inc..(Bourke, Mary)
January 9, 2023 Filing 87 NOTICE to Take Deposition of Matthew J. Hamilton on between May 1, 2023 and May 25, 2023 filed by Ferring Pharmaceuticals Inc., Rebiotix Inc..(Bourke, Mary)
January 9, 2023 Filing 86 NOTICE to Take Deposition of Michael J. Sadowsky on between May 1, 2023 and May 25, 2023 filed by Ferring Pharmaceuticals Inc., Rebiotix Inc..(Bourke, Mary)
January 9, 2023 Filing 85 NOTICE to Take Deposition of Alexander Khoruts on between May 1, 2023 and May 25, 2023 filed by Ferring Pharmaceuticals Inc., Rebiotix Inc..(Bourke, Mary)
January 9, 2023 Filing 84 NOTICE to Take Deposition of Russ Straate on between April 1, 2023 and April 30, 2023 filed by Ferring Pharmaceuticals Inc., Rebiotix Inc..(Bourke, Mary)
January 9, 2023 Filing 83 NOTICE to Take Deposition of Kevin Anderson on between April 1, 2023 and April 30, 2023 filed by Ferring Pharmaceuticals Inc., Rebiotix Inc..(Bourke, Mary)
January 9, 2023 Filing 82 NOTICE to Take Deposition of William Kieper on between April 1, 2023 and April 30, 2023 filed by Ferring Pharmaceuticals Inc., Rebiotix Inc..(Bourke, Mary)
January 9, 2023 Filing 81 NOTICE to Take Deposition of James Burgess on between March 6, 2023 and March 31, 2023 filed by Ferring Pharmaceuticals Inc., Rebiotix Inc..(Bourke, Mary)
January 9, 2023 Filing 80 NOTICE to Take Deposition of Mark Smith on between March 6, 2023 and March 31, 2023 filed by Ferring Pharmaceuticals Inc., Rebiotix Inc..(Bourke, Mary)
January 3, 2023 Filing 79 NOTICE OF SERVICE of Plaintiffs' Objections and Responses to Counterclaim-Plaintiffs' Third Set of Requests for Production of Documents and Things (Nos. 132-140) filed by Ferring Pharmaceuticals Inc., Rebiotix Inc..(Attaway, Daniel)
December 29, 2022 Filing 78 NOTICE OF SERVICE of Fourth Set of Requests for Production of Documents and Things (Nos. 141-154) filed by Finch Therapeutics Group, Inc., Finch Therapeutics Holdings, LLC., Finch Therapeutics, Inc., Regents of the University of Minnesota.(Pedi, Nicole)
December 22, 2022 Opinion or Order Filing 77 ORAL ORDER: The parties have advised that a dispute has arisen requiring attention. The Court will hold a discovery conference on 2/2/2023, at 3:00 PM in Courtroom 6A. In preparation for this conference the parties shall follow the Discovery Matters and Disputes procedure as set forth in the Scheduling Order. Ordered by Judge Richard G. Andrews on 12/22/2022. (nms)
December 21, 2022 Filing 76 NOTICE OF SERVICE of (1) Plaintiffs' Second Set of Interrogatories to Finch Therapeutics Group, Inc., Finch Therapeutics, Inc., Finch Therapeutics Holdings, LLC, and the Regents of the University of Minnesota (Nos. 9-12); (2) Plaintiffs' Third Set of Requests to the Regents of the University of Minnesota for the Production of Documents and Things (Nos. 130-136) filed by Ferring Pharmaceuticals Inc., Rebiotix Inc..(Bourke, Mary)
November 30, 2022 Filing 75 NOTICE OF SERVICE of Counterclaim-Plaintiffs Third Set of Requests for Production of Documents and Things (Nos. 132-140) filed by Finch Therapeutics Group, Inc., Finch Therapeutics Holdings, LLC., Finch Therapeutics, Inc., Regents of the University of Minnesota.(Farnan, Kelly)
November 30, 2022 Filing 74 NOTICE of Subpoena to Testify at Deposition Directed to Thomas Borody by Ferring Pharmaceuticals Inc., Rebiotix Inc. (Bourke, Mary)
November 30, 2022 Filing 73 NOTICE to Take Deposition of Dr. Jessica Allegretti on between December 21, 2022 and January 6, 2023 filed by Ferring Pharmaceuticals Inc., Rebiotix Inc..(Bourke, Mary)
November 23, 2022 Filing 72 NOTICE to Take Deposition of Dr. Richard Alan Johnson on no later than Dec 12, 2022 filed by Finch Therapeutics Group, Inc., Finch Therapeutics Holdings, LLC., Finch Therapeutics, Inc., Regents of the University of Minnesota.(Farnan, Kelly)
November 21, 2022 Filing 71 STIPULATION TO EXTEND TIME for the parties to substantially complete document production to through and including December 22, 2022 - filed by Finch Therapeutics Group, Inc., Finch Therapeutics Holdings, LLC., Finch Therapeutics, Inc., Regents of the University of Minnesota. (Farnan, Kelly)
November 21, 2022 Opinion or Order SO ORDERED, re #71 STIPULATION and Proposed Order to Extend Time for Substantial Completion of Document Production. Signed by Judge Richard G. Andrews on 11/21/2022. (nms)
November 10, 2022 Filing 70 NOTICE OF SERVICE of Plaintiffs' Answering Claim Construction Brief and Declaration of Dr. Richard Alan Johnson filed by Ferring Pharmaceuticals Inc., Rebiotix Inc..(Attaway, Daniel)
November 3, 2022 Filing 69 NOTICE OF SERVICE of Non-Party Michael Berman's Objections and Responses to Counterclaimants' Notice of Subpoena filed by Ferring Pharmaceuticals Inc., Rebiotix Inc..(Bourke, Mary)
October 12, 2022 Filing 68 NOTICE of Subpoena to Michael Berman to Testify at a Deposition and to Produce Documents, Information or Objects or to Permit Inspection of Premises by Finch Therapeutics Group, Inc., Finch Therapeutics Holdings, LLC., Finch Therapeutics, Inc., Regents of the University of Minnesota (Attachments: #1 Exhibit 1, #2 Exhibit 2)(Farnan, Kelly)
October 3, 2022 Filing 67 NOTICE OF SERVICE of 1) Objections and Responses to Second Set of Requests for the Production of Documents and Things (Nos. 78-131); 2) Objections and Responses to Second Set of Requests for the Production of Documents and Things (Nos. 78-128); and Responses and Objections to First Set of Interrogatories (Nos. 1-8) filed by Finch Therapeutics Group, Inc., Finch Therapeutics Holdings, LLC., Finch Therapeutics, Inc., Regents of the University of Minnesota.(Pedi, Nicole)
September 19, 2022 Opinion or Order Filing 66 SO ORDERED, re #65 Stipulation and Proposed Order to Extend Time. Signed by Judge Richard G. Andrews on 9/19/2022. (lah)
September 16, 2022 Filing 65 STIPULATION and Proposed Order to Extend Time - filed by Ferring Pharmaceuticals Inc., Rebiotix Inc.. (Attaway, Daniel) Modified on 9/19/2022 (nms).
September 13, 2022 Filing 64 Joint Claim Construction Chart, by Ferring Pharmaceuticals Inc., Rebiotix Inc.. (Attachments: #1 Exhibit 1, #2 Exhibit 2, #3 Exhibit 3, #4 Exhibit 4, #5 Exhibit 5, #6 Exhibit 6, #7 Exhibit 7, #8 Exhibit 8, #9 Exhibit 9, #10 Exhibit 10, #11 Exhibit 11, #12 Exhibit 12, #13 Exhibit 13, #14 Exhibit 14, #15 Exhibit 15, #16 Exhibit 16, #17 Exhibit 17, #18 Exhibit 18, #19 Exhibit 19, #20 Exhibit 20, #21 Exhibit 21, #22 Exhibit 22, #23 Exhibit 23, #24 Exhibit 24, #25 Exhibit 25, #26 Exhibit 26, #27 Exhibit 27, #28 Exhibit 28, #29 Exhibit 29, #30 Exhibit 30, #31 Exhibit 31, #32 Exhibit 32, #33 Exhibit 33, #34 Exhibit 34, #35 Exhibit 35, #36 Exhibit 36, #37 Exhibit 37, #38 Exhibit 38, #39 Exhibit 39, #40 Exhibit 40, #41 Exhibit 41, #42 Exhibit 42, #43 Exhibit 43, #44 Exhibit 44, #45 Exhibit 45, #46 Exhibit 46, #47 Exhibit 47, #48 Exhibit 48, #49 Exhibit 49, #50 Exhibit 50, #51 Exhibit 51, #52 Exhibit 52)(Bourke, Mary) Modified on 9/14/2022 (nms).
September 9, 2022 Filing 63 STIPULATION TO EXTEND TIME to file the Joint Claim Construction Chart and for service of Finch's opening claim construction brief to September 13, 2022 and October 10, 2022 - filed by Ferring Pharmaceuticals Inc., Rebiotix Inc.. (Attaway, Daniel)
September 9, 2022 Opinion or Order SO ORDERED, re #63 STIPULATION and Proposed Order to Extend Time to file the Joint Claim Construction Chart and for service of Finch's opening claim construction brief to September 13, 2022 and October 10, 2022. Signed by Judge Richard G. Andrews on 9/9/2022. (nms)
September 7, 2022 Filing 62 STIPULATION TO EXTEND TIME to file the Joint Claim Construction Chart to September 9, 2022 - filed by Ferring Pharmaceuticals Inc., Rebiotix Inc.. (Attaway, Daniel)
September 7, 2022 Opinion or Order SO ORDERED, re #62 STIPULATION and Proposed Order to Extend Time to file the Joint Claim Construction Chart to September 9, 2022. Signed by Judge Richard G. Andrews on 9/7/2022. (nms)
September 6, 2022 Filing 61 NOTICE OF SERVICE of Plaintiffs' Objections and Responses to Counterclaim-Plaintiffs' Second Set of Requests for Production of Documents and Things (Nos. 119-131) filed by Ferring Pharmaceuticals Inc., Rebiotix Inc..(Bourke, Mary)
August 22, 2022 Filing 60 NOTICE OF SERVICE of Finch Therapeutics Group, Inc., Finch Therapeutics, Inc., Finch Therapeutics Holdings, LLC, and Regent of the University of Minnesota's list of claim terms for construction filed by Finch Therapeutics Group, Inc., Finch Therapeutics Holdings, LLC., Finch Therapeutics, Inc., Regents of the University of Minnesota.(Pedi, Nicole)
August 12, 2022 Filing 59 NOTICE OF SERVICE of (1) Plaintiffs First Set of Interrogatories to Finch Therapeutics Group, Inc., Finch Therapeutics, Inc., Finch Therapeutics Holdings, LLC, and the Regents of the University of Minnesota (Nos. 1-8); (2) Plaintiffs' Second Set of Requests to the Regents of the University of Minnesota for the Production of Documents and Things (Nos. 78-129), and (3) Plaintiffs' Second Set of Requests to Finch Therapeutics Group, Inc., Finch Therapeutics, Inc., and Finch Therapeutics Holdings, LLC for the Production of Documents and Things (Nos. 78-131) filed by Ferring Pharmaceuticals Inc., Rebiotix Inc..(Bourke, Mary)
August 12, 2022 Filing 58 NOTICE OF SERVICE of Plaintiffs Ferring Pharmaceuticals Inc. and Rebiotix Inc.'s Initial Invalidity Contentions for the Asserted Claims of the Patents in Suit filed by Ferring Pharmaceuticals Inc., Rebiotix Inc..(Bourke, Mary)
August 12, 2022 Filing 57 NOTICE OF SERVICE of Plaintiffs' Notice of Subpoena of Thomas J. Borody filed by Ferring Pharmaceuticals Inc., Rebiotix Inc..(Bourke, Mary)
August 8, 2022 Filing 56 NOTICE OF SERVICE of Plaintiffs' Objections and Responses to Finch and UMN's Second Set of Interrogatories (Nos. 8-9) filed by Ferring Pharmaceuticals Inc., Rebiotix Inc..(Bourke, Mary)
August 5, 2022 Filing 55 NOTICE OF SERVICE of Counterclaim- Plaintiffs Second Set of Requests for Production of Documents and Things (Nos. 119-131) filed by Finch Therapeutics Group, Inc., Finch Therapeutics Holdings, LLC., Finch Therapeutics, Inc., Regents of the University of Minnesota.(Farnan, Kelly)
July 22, 2022 Filing 54 NOTICE OF SERVICE of Plaintiffs' Objections and Responses to Finch and UMN's First Set of Interrogatories (Nos. 1-7) filed by Ferring Pharmaceuticals Inc., Rebiotix Inc..(Bourke, Mary)
July 12, 2022 Opinion or Order SO ORDERED, re #52 STIPULATION and Proposed Order to Extend Time. Signed by Judge Richard G. Andrews on 7/12/2022. (nms)
July 8, 2022 Filing 53 NOTICE OF SERVICE of Counterclaim- Plaintiffs Second Set of Interrogatories (Nos. 8-9) filed by Finch Therapeutics Group, Inc., Finch Therapeutics Holdings, LLC., Finch Therapeutics, Inc., Regents of the University of Minnesota.(Farnan, Kelly)
July 8, 2022 Filing 52 STIPULATION and Proposed Order to Extend Time - filed by Ferring Pharmaceuticals Inc., Rebiotix Inc.. (Attaway, Daniel) Modified on 7/8/2022 (nms).
June 16, 2022 Filing 51 STIPULATION TO EXTEND TIME for OpenBiome to respond to Plaintiffs' Subpoena to Produce Documents to July 1, 2022 - filed by Ferring Pharmaceuticals Inc., Rebiotix Inc.. (Bourke, Mary)
June 16, 2022 Opinion or Order SO ORDERED, re #51 STIPULATION and Proposed Order to Extend Time to respond to Subpoena to Produce Documents to July 1, 2022. Signed by Judge Richard G. Andrews on 6/16/2022. (nms)
June 15, 2022 Filing 50 NOTICE OF SERVICE of Finch Therapeutics Group, Inc., Finch Therapeutics, Inc., Finch Therapeutics Holdings, LLC, and Regents of the University of Minnesota's: 1) Initial Infringement Contentions; and 2) First Set of Interrogatories (Nos. 1-7) filed by Finch Therapeutics Group, Inc., Finch Therapeutics Holdings, LLC., Finch Therapeutics, Inc., Regents of the University of Minnesota.(Pedi, Nicole)
June 6, 2022 Filing 49 SUBPOENA Returned Executed as to Microbiome Health Research Institute, doing business as OpenBiome on June 3, 2022 (Bourke, Mary)
June 2, 2022 Filing 48 NOTICE of Subpoena on Microbiome Health Research Institute d/b/a OpenBiome, by Ferring Pharmaceuticals Inc., Rebiotix Inc. (Bourke, Mary) Modified on 6/3/2022 (nms).
May 24, 2022 Filing 47 NOTICE OF SERVICE of Finch Therapeutics Group, Inc., Finch Therapeutics, Inc., Finch Therapeutics Holdings, LLC, and Regents of the University of Minnesota's Initial Search Term List filed by Finch Therapeutics Group, Inc., Finch Therapeutics Holdings, LLC., Finch Therapeutics, Inc., Regents of the University of Minnesota.(Farnan, Kelly)
May 12, 2022 Opinion or Order Filing 46 SO ORDERED Granting #45 Stipulated Protective Order. Signed by Judge Richard G. Andrews on 5/12/2022. (nms)
May 11, 2022 Filing 45 PROPOSED Stipulated Protective Order, by Ferring Pharmaceuticals Inc., Rebiotix Inc.. (Bourke, Mary) Modified on 5/12/2022 (nms).
May 11, 2022 Opinion or Order Filing 44 STIPULATION and Order Regarding Discovery, Including Discovery of Electronically Stored Information ("ESI"). Signed by Judge Richard G. Andrews on 5/11/2022. (nms)
May 11, 2022 Opinion or Order Filing 43 ORAL ORDER: The Court has reviewed the protective order dispute submissions. (D.I. #38 , #39 ). The Court decides that there should be only two levels of confidentiality. Highly Confidential information is for outside counsel only. Confidential information may be shared with in-house counsel. The prosecution bar is only necessary for the Highly Confidential information. The risk of inadvertent disclosure for Confidential information is not so great that it justifies a prosecution bar. Documents may not be redacted for non-responsiveness. The Court requests that the parties edit the proposed protective order to conform with the above. Ordered by Judge Richard G. Andrews on 5/11/2022. (nms)
May 4, 2022 Filing 42 NOTICE OF SERVICE of Plaintiffs' Objections and Responses to Counterclaim-Plaintiffs' First Set of Requests for Production of Documents and Things (Nos. 1-114) filed by Ferring Pharmaceuticals Inc., Rebiotix Inc..(Bourke, Mary)
May 4, 2022 Filing 41 NOTICE OF SERVICE of Edwin Hlavka's Objections and Responses to Defendants' Notice of Subpoena filed by Ferring Pharmaceuticals Inc., Rebiotix Inc..(Bourke, Mary)
May 2, 2022 Filing 40 ANSWER to #30 Counterclaim by Finch Therapeutics Group, Inc., Finch Therapeutics Holdings, LLC., Finch Therapeutics, Inc., Regents of the University of Minnesota.(Farnan, Kelly)
April 25, 2022 Filing 39 Letter to The Honorable Richard G. Andrews, from Daniel M. Attaway, regarding protective order dispute. (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Exhibit C, #4 Exhibit D)(Attaway, Daniel) Modified on 4/26/2022 (nms).
April 25, 2022 Filing 38 Letter to Honorable Richard G. Andrews, from Kelly E. Farnan, regarding disputes concerning proposed protective order. (Farnan, Kelly) Modified on 4/26/2022 (nms).
April 25, 2022 Filing 37 STIPULATION TO EXTEND TIME for Counterclaimants to move, reply, or otherwise respond to Plaintiffs' Counterclaims in Reply to Counterclaimants' First Amended Answer and the deadline for Mr. Edwin Hlavka to respond or move to quash Defendants subpoena to produce documents to May 2, 2022 and May 4, 2022 - filed by Ferring Pharmaceuticals Inc., Rebiotix Inc.. (Bourke, Mary)
April 25, 2022 Opinion or Order SO ORDERED, re #37 STIPULATION and Proposed Order to Extend Time for Counterclaimants to move, reply, or otherwise respond to Counterclaims in and the deadline for Mr. Edwin Hlavka to respond or move to quash subpoena. Signed by Judge Richard G. Andrews on 4/25/2022. (nms)
April 22, 2022 Filing 36 NOTICE OF SERVICE of 1) Defendants Finch Therapeutics Groups, Inc., Finch Therapeutics, Inc. and Finch Therapeutics Holdings, LLC's Amended Initial Disclosures Pursuant to Paragraph 3 of the Delaware Default Standard for Discovery; and 2) Counterclaim-Plaintiff The Regents of the University of Minnesota's Amended Initial Disclosures Pursuant to Paragraph 3 of the Delaware Default Standard for Discovery filed by Finch Therapeutics Group, Inc., Finch Therapeutics Holdings, LLC., Finch Therapeutics, Inc., Regents of the University of Minnesota.(Pedi, Nicole)
April 21, 2022 Filing 35 MOTION for Pro Hac Vice Appearance of Attorney Michael W. De Vries, Adam R. Alper, Patricia A. Carson, Ashley L.B. Ross and Alina Afinogenova - filed by Regents of the University of Minnesota. (Pedi, Nicole)
April 21, 2022 Opinion or Order SO ORDERED, re #35 MOTION for Pro Hac Vice Appearance of Attorney Michael W. De Vries, Adam R. Alper, Patricia A. Carson, Ashley L.B. Ross and Alina Afinogenova, filed by Regents of the University of Minnesota. Signed by Judge Richard G. Andrews on 4/21/2022. (nms)
April 18, 2022 Filing 34 NOTICE OF SERVICE of 1) Defendants/Counterclaim-Plaintiffs Finch Therapeutics Groups, Inc., Finch Therapeutics, Inc. and Finch Therapeutics Holdings, LLC's Objections and Responses to Plaintiff's First Set of Requests For the Production of Documents and Things (Nos. 1-77); and 2) Counterclaim-Plaintiff The Regents of the University of Minnesota's Objections and Responses to Plaintiff's First Set of Requests For the Production of Documents and Things (Nos. 1-77) filed by Finch Therapeutics Group, Inc., Finch Therapeutics Holdings, LLC., Finch Therapeutics, Inc., Regents of the University of Minnesota.(Pedi, Nicole)
April 18, 2022 Opinion or Order SO ORDERED, re #33 STIPULATION TO EXTEND TIME for the parties to submit a Proposed Protective Order and ESI Order to April 22, 2022. Signed by Judge Richard G. Andrews on 4/18/2022. (nms)
April 13, 2022 Filing 33 STIPULATION TO EXTEND TIME for the parties to submit a Proposed Protective Order and ESI Order to April 22, 2022 - filed by Ferring Pharmaceuticals Inc., Rebiotix Inc.. (Bourke, Mary)
April 6, 2022 Filing 32 STIPULATION TO EXTEND TIME for the parties to submit a Proposed Protective Order and ESI Order to April 13, 2022 - filed by Ferring Pharmaceuticals Inc., Rebiotix Inc.. (Bourke, Mary)
April 6, 2022 Opinion or Order SO ORDERED, re #32 STIPULATION TO EXTEND TIME for the parties to submit a Proposed Protective Order and ESI Order to April 13, 2022. Signed by Judge Richard G. Andrews on 4/6/2022. (nms)
April 4, 2022 Filing 31 NOTICE OF SERVICE of First Set of Requests for Production of Documents and Things (1-114) filed by Finch Therapeutics Group, Inc., Finch Therapeutics Holdings, LLC., Finch Therapeutics, Inc..(Pedi, Nicole)
April 4, 2022 Filing 30 Reply and Counterclaims to #19 First Amended Counterclaims - filed by Ferring Pharmaceuticals Inc., Rebiotix Inc.. (Attachments: #1 Exhibit 1)(Bourke, Mary) Modified on 4/5/2022 (nms).
April 4, 2022 Filing 29 NOTICE OF SERVICE of Initial Disclosures filed by Finch Therapeutics Group, Inc., Finch Therapeutics Holdings, LLC., Finch Therapeutics, Inc..(Pedi, Nicole)
April 4, 2022 Filing 28 NOTICE OF SERVICE of Plaintiffs Rule 26(A)(1)(a) and Paragraph 3 Disclosures filed by Ferring Pharmaceuticals Inc., Rebiotix Inc..(Bourke, Mary)
April 4, 2022 Filing 27 NOTICE OF SERVICE of the patents in suit and the file history for each of the patents in suit filed by Finch Therapeutics Group, Inc., Finch Therapeutics Holdings, LLC., Finch Therapeutics, Inc..(Pedi, Nicole)
March 31, 2022 Opinion or Order SO ORDERED, re #26 STIPULATION TO EXTEND TIME to Serve Initial Disclosures pursuant to Federal Rule of Civil Procedure 26(a)(1) and Disclosures required under Paragraph 3 of the Default Standard Discovery to April 4, 2022. Signed by Judge Richard G. Andrews on 3/31/2022. (nms)
March 30, 2022 Filing 26 STIPULATION TO EXTEND TIME to Serve Initial Disclosures pursuant to Federal Rule of Civil Procedure 26(a)(1) and Disclosures required under Paragraph 3 of the Default Standard Discovery to April 4, 2022 - filed by Finch Therapeutics Group, Inc., Finch Therapeutics Holdings, LLC., Finch Therapeutics, Inc.. (Farnan, Kelly)
March 29, 2022 Filing 25 STIPULATION TO EXTEND TIME the deadline for the parties to submit a Proposed Protective Order to through and including April 6, 2022 - filed by Finch Therapeutics Group, Inc., Finch Therapeutics Holdings, LLC.. (Farnan, Kelly)
March 29, 2022 Opinion or Order SO ORDERED, re #25 STIPULATION to Extend Time for the parties to submit a Proposed Protective Order to through and including April 6, 2022. Signed by Judge Richard G. Andrews on 3/29/2022. (nms)
March 18, 2022 Filing 24 NOTICE of Appearance by Zachary Thomas Grieb Murphy on behalf of Ferring Pharmaceuticals Inc., Rebiotix Inc. (Murphy, Zachary)
March 18, 2022 Opinion or Order Filing 23 SO ORDERED, re #22 STIPULATION TO EXTEND TIME to file proposed Protective Order to March 30, 2022. Signed by Judge Richard G. Andrews on 3/18/2022. (nms)
March 18, 2022 Filing 22 STIPULATION TO EXTEND TIME to file proposed Protective Order to March 30, 2022 - filed by Ferring Pharmaceuticals Inc., Rebiotix Inc.. (Attaway, Daniel)
March 16, 2022 Filing 21 NOTICE OF SERVICE of (1) Plaintiffs' First Set of Requests to Finch Therapeutics Group, Inc., Finch Therapeutics, Inc., and Finch Therapeutics Holdings, LLC for the Production of Documents and Things (Nos. 1-77) and (2) Plaintiffs' First Set of Requests to the Regents of the University of Minnesota for the Production of Documents and Things (Nos. 1-77) filed by Ferring Pharmaceuticals Inc., Rebiotix Inc..(Bourke, Mary)
March 7, 2022 Filing 20 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,251,914; 10,286,011; 10,286,012. (Farnan, Kelly) Modified on 3/8/2022 (nms).
March 7, 2022 Filing 19 ANSWER to #1 Complaint, and Amended Counterclaims against Ferring Pharmaceuticals, Inc. and Rebiotix, Inc., by Finch Therapeutics Group, Inc., Finch Therapeutics, Inc., Finch Therapeutics Holdings, LLC, and Regents of the University of Minnesota. (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Exhibit C, #4 Exhibit D, #5 Exhibit E, #6 Exhibit F, #7 Exhibit G, #8 Exhibit H, #9 Exhibit I, #10 Exhibit J, #11 Exhibit K, #12 Exhibit L, #13 Exhibit M, #14 Exhibit N, #15 Exhibit O, #16 Exhibit P, #17 Exhibit Q, #18 Exhibit R, #19 Exhibit S, #20 Exhibit T, #21 Exhibit U, #22 Exhibit V, #23 Exhibit W, #24 Exhibit X)(Farnan, Kelly) Modified on 3/8/2022 (nms). Modified on 4/5/2022 (nms).
February 28, 2022 Opinion or Order Filing 18 ORAL ORDER: The Rule 16(b) Conference scheduled for 3/2/2022, is CANCELED. Ordered by Judge Richard G. Andrews on 2/28/2022. (nms)
February 28, 2022 Opinion or Order Filing 17 SCHEDULING ORDER: Case referred to the Magistrate Judge for the purpose of exploring ADR. Joinder of Parties due by 4/28/2023. Amended Pleadings due by 4/28/2023. Fact Discovery completed by 5/25/2023. Dispositive Motions due by 12/8/2023. Answering Brief due 1/9/2024. Reply Brief due 1/24/2024. Joint Claim Construction Brief due by 1/20/2023. A Markman Hearing is set for 2/21/2023, at 9:00 AM in Courtroom 6A. A Pretrial Conference is set for 5/10/2024, at 9:00 AM in Courtroom 6A. A 5 day Jury Trial is set to start 5/20/2024, at 9:30 AM in Courtroom 6A (see Order for further details). Signed by Judge Richard G. Andrews on 2/28/2022. (nms)
February 28, 2022 Filing 16 PROPOSED Scheduling Order, by Ferring Pharmaceuticals Inc., Rebiotix Inc.. (Bourke, Mary) Modified on 2/28/2022 (nms).
February 28, 2022 Filing 15 Letter to The Honorable Richard G. Andrews, from Mary W. Bourke, Esq., regarding dial-in information for the Rule 16(b) Telephone Conference. (Bourke, Mary) Modified on 2/28/2022 (nms).
February 14, 2022 Pro Hac Vice Attorney Michael W. De Vries, Adam R. Alper, Ashley L.B. Ross, Alina Afinogenova, Patricia A. Carson for Finch Therapeutics Group, Inc., Finch Therapeutics Holdings, LLC., Finch Therapeutics, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (twk)
February 11, 2022 Filing 14 STIPULATION TO EXTEND TIME to move, answer or otherwise respond to Defendants/Counterclaim Plaintiffs Counterclaims (D.I. 10) to March 14, 2022 - filed by Ferring Pharmaceuticals Inc., Rebiotix Inc.. (Bourke, Mary)
February 11, 2022 Opinion or Order SO ORDERED, re #14 STIPULATION and Proposed Order to Extend Time (*Reset Answer Deadlines: Ferring Pharmaceuticals Inc. answer due 3/14/2022; Rebiotix Inc. answer due 3/14/2022). Signed by Judge Richard G. Andrews on 2/11/2022. (nms)
February 10, 2022 Filing 13 MOTION for Pro Hac Vice Appearance of Attorney Michael W. De Vries, Adam R. Alper, Patricia A. Carson, Ashley Ross and Alina Afinogenova - filed by Finch Therapeutics Group, Inc., Finch Therapeutics Holdings, LLC., Finch Therapeutics, Inc.. (Farnan, Kelly)
February 10, 2022 Opinion or Order Filing 12 Order Setting Rule 16(b) Telephone Conference: A Scheduling Conference is set for 3/2/2022, at 9:00 AM before Judge Richard G. Andrews (see Order for further details). Signed by Judge Richard G. Andrews on 2/10/2022. (nms)
February 10, 2022 Opinion or Order SO ORDERED, re #13 MOTION for Pro Hac Vice Appearance of Attorney Michael W. De Vries, Adam R. Alper, Patricia A. Carson, Ashley Ross and Alina Afinogenova, filed by Finch Therapeutics, Inc., Finch Therapeutics Group, Inc., Finch Therapeutics Holdings, LLC.. Signed by Judge Richard G. Andrews on 2/10/2022. (nms)
February 7, 2022 Filing 11 Disclosure Statement pursuant to Rule 7.1: identifying filed by Finch Therapeutics Group, Inc., Finch Therapeutics Holdings, LLC., Finch Therapeutics, Inc.. (Farnan, Kelly)
February 7, 2022 Filing 10 ANSWER to #1 Complaint, and COUNTERCLAIMS against Ferring Pharmaceuticals Inc., Rebiotix Inc., by Finch Therapeutics Group, Inc., Finch Therapeutics Holdings, LLC., Finch Therapeutics, Inc.. (Attachments: #1 Exhibits A-O, #2 Exhibit P, #3 Exhibit Q-T)(Farnan, Kelly) Modified on 2/8/2022 (nms).
December 14, 2021 Filing 9 STIPULATION TO EXTEND TIME to Answer Complaint to through and including February 7, 2022 - filed by Finch Therapeutics Group, Inc., Finch Therapeutics Holdings, LLC., Finch Therapeutics, Inc.. (Farnan, Kelly)
December 14, 2021 Opinion or Order SO ORDERED, re #9 STIPULATION to Extend Time (*Reset Answer Deadlines: Finch Therapeutics Group, Inc. answer due 2/7/2022; Finch Therapeutics Holdings, LLC. answer due 2/7/2022; Finch Therapeutics, Inc. answer due 2/7/2022). Signed by Judge Richard G. Andrews on 12/14/2021. (nms)
December 8, 2021 Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. (rjb)
December 2, 2021 Filing 8 SUMMONS Returned Executed by Rebiotix Inc., Ferring Pharmaceuticals Inc.. Finch Therapeutics, Inc. served on 12/1/2021, answer due 12/22/2021. (Bourke, Mary)
December 2, 2021 Filing 7 SUMMONS Returned Executed by Rebiotix Inc., Ferring Pharmaceuticals Inc.. Finch Therapeutics Holdings, LLC. served on 12/1/2021, answer due 12/22/2021. (Bourke, Mary)
December 2, 2021 Filing 6 SUMMONS Returned Executed by Rebiotix Inc., Ferring Pharmaceuticals Inc.. Finch Therapeutics Group, Inc. served on 12/1/2021, answer due 12/22/2021. (Bourke, Mary)
December 1, 2021 Filing 5 Summons Issued with Magistrate Consent Notice attached as to Finch Therapeutics Group, Inc. on 12/1/2021; Finch Therapeutics Holdings, LLC. on 12/1/2021; Finch Therapeutics, Inc. on 12/1/2021. (Attachments: #1 Summons Issued Finch Therapeutics Holdings, LLC, #2 Summons Issued Finch Therapeutics, Inc.)(apk)
December 1, 2021 Filing 4 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Ferring Holding Inc. for Ferring Pharmaceuticals Inc., Rebiotix Inc. filed by Ferring Pharmaceuticals Inc., Rebiotix Inc.. (apk)
December 1, 2021 Filing 3 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 10,675,309 ;US 10,463,702 ;US 10,328,107 ;US 10,064,899 ;US 10,022,406 ;US 9,962,413 ;US 9,308,226. (apk)
December 1, 2021 Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (apk)
December 1, 2021 Filing 1 COMPLAINT filed against Finch Therapeutics Group, Inc., Finch Therapeutics Holdings, LLC., Finch Therapeutics, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 402, receipt number ADEDC-3753180.) - filed by Rebiotix Inc., Ferring Pharmaceuticals Inc.. (Attachments: #1 Exhibit 1, #2 Exhibit 2, #3 Exhibit 3, #4 Exhibit 4, #5 Exhibit 5, #6 Exhibit 6, #7 Exhibit 7, #8 Exhibit 8, #9 Exhibit 9, #10 Exhibit 10, #11 Exhibit 11, #12 Exhibit 12, #13 Exhibit 13, #14 Exhibit 14, #15 Exhibit 15, #16 Exhibit 16, #17 Exhibit 17, #18 Exhibit 18, #19 Exhibit 19, #20 Exhibit 20, #21 Exhibit 21, #22 Exhibit 22, #23 Exhibit 23, #24 Exhibit 24, #25 Exhibit 25, #26 Exhibit 26, #27 Exhibit 27, #28 Exhibit 28, #29 Exhibit 29, #30 Exhibit 30, #31 Exhibit 31, #32 Civil Cover Sheet)(apk)

Access additional case information on PACER

Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.

Access this case on the Delaware District Court's Electronic Court Filings (ECF) System

Search for this case: Ferring Pharmaceuticals Inc. et al v. Finch Therapeutics Group, Inc. et al
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Web [ Unicourt | Legal Web | Google | Bing | Yahoo | Ask ]
Plaintiff: Ferring Pharmaceuticals Inc.
Represented By: Mary W. Bourke
Represented By: Ben Bourke
Represented By: Dana Kathryn Severance
Represented By: Daniel Marcus Attaway
Represented By: Zachary Thomas Grieb Murphy
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Plaintiff: Rebiotix Inc.
Represented By: Dana Kathryn Severance
Represented By: Daniel Marcus Attaway
Represented By: Mary W. Bourke
Represented By: Ben Bourke
Represented By: Zachary Thomas Grieb Murphy
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Finch Therapeutics Group, Inc.
Represented By: Kelly E. Farnan
Represented By: Adam R. Alper
Represented By: Alina Afinogenova
Represented By: Ashley Cade
Represented By: Ashley L.B. Ross
Represented By: Leslie M. Schmidt
Represented By: Michael W. De Vries
Represented By: Nicole Kathleen Pedi
Represented By: Patricia A. Carson
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Finch Therapeutics, Inc.
Represented By: Kelly E. Farnan
Represented By: Adam R. Alper
Represented By: Alina Afinogenova
Represented By: Ashley Cade
Represented By: Ashley L.B. Ross
Represented By: Leslie M. Schmidt
Represented By: Michael W. De Vries
Represented By: Nicole Kathleen Pedi
Represented By: Patricia A. Carson
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Finch Therapeutics Holdings, LLC.
Represented By: Kelly E. Farnan
Represented By: Adam R. Alper
Represented By: Alina Afinogenova
Represented By: Ashley Cade
Represented By: Ashley L.B. Ross
Represented By: Leslie M. Schmidt
Represented By: Michael W. De Vries
Represented By: Nicole Kathleen Pedi
Represented By: Patricia A. Carson
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Counter claimant: Regents of the University of Minnesota
Represented By: Nicole Kathleen Pedi
Represented By: Kelly E. Farnan
Represented By: Ashley Cade
Represented By: Leslie M. Schmidt
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.

Why Is My Information Online?